The Johnson & Johnson vaccine will mark the third #Covid19 vaccine approved by the FDA for emergency use, and the mainstream media is already praising it. Jefferey Jaxen breaks down the fine print on the experimental drug’s efficacy, as well as the unknown risks and data gaps published by the FDA themselves.
#JohnsonJohnson #VaccineRollout #VaccineSafety #VaccineEfficacy #FDA #DataGaps #EmergencyApproval #RiskVsReward #DelBigtree #TheHighWire
Related posts:
- The Final Brick in the Vaccine Efficacy Narrative
- Experts explain why vaccines against Covid-19 are unnecessary and dangerous
- WHO Says: No Evidence” that COVID-19 Vaccines Will Prevent Spread
- 11 Pieces of Information That Can Alter The Course Of Your Life
- FDA Study: COVID Vaccine Linked to Blood Clotting in Elderly
- COVID-19 Vaccine Injuries and Deaths Continue to Climb, New VAERS Data Show